Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus magnesium sulfate for bleeding control during tympanoplasty
IRCT20120215009014N427Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in tympanic membrane perforation comparing Dexmedetomidine with Magnesium sulfate (2 arms). Primary endpoints: Intraoperative bleeding volume and Surgeon satisfaction. Started Jun 2022; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on IRCT20120215009014N427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N427.